Equities Analysts Offer Predictions for CGEM FY2024 Earnings

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) – Equities researchers at Leerink Partnrs increased their FY2024 earnings estimates for Cullinan Therapeutics in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now expects that the company will earn ($2.88) per share for the year, up from their previous estimate […]